Delivery Order SPE2DB20D1100-SPE2DB25FC0A6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,618.80 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50 milliliters. This contract represents a competitively awarded, non-set-aside delivery order with firm fixed pricing under an Indefinite Delivery Contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,668.21 on June 16, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50 units. This firm fixed price contract, which was not set-aside, is set for completion by June 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical support services through the company's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.48 to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, with an ultimate completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its pharmaceutical distribution operations...
- The Defense Logistics Agency awarded a $1,434.58 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50 units. This competitively awarded, firm fixed-price contract is set to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger vehicle, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- The Defense Logistics Agency awarded a delivery order valued at $18,947.32 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50s, a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.62 to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, an antibiotic pharmaceutical product. The contract was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, using firm fixed price terms without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- This delivery order, valued at $3,055.46, was awarded to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride (1 gram/50 milliliters) to support federal medical procurement needs. The contract employs firm fixed pricing and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal government's military and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.22 firm-fixed-price contract is for the delivery of 1 gram vials of the antibiotic Meropenem in 0.9% sodium chloride solution. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC0A6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,928.76 to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Meropenem 0.9% Saline solution (1 gram/50s) with performance completion by April 30, 2025. This competitive, non-set-aside award utilizes a firm fixed price structure and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply medications, medical devices, and healthcare commodities to military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. Meropenem, a broad-spectrum antibiotic, represents the type of critical pharmaceutical commodity supported through this global supply framework for military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 4/29/25 |